Stickings P, Mistry S K, Boucher J-L, Morris S M, Cunningham J M
School of Pharmacy and Biomolecular Sciences, University of Brighton, Cockcroft Building Lewes Rd, Brighton, East Sussex, BN2 4GJ UK.
Nitric Oxide. 2002 Dec;7(4):289-96. doi: 10.1016/s1089-8603(02)00122-2.
Proinflammatory cytokine induction of NO synthesis may contribute to the destruction of pancreatic beta cells leading to type 1 diabetes. The NO synthase substrate arginine can also be metabolized to ornithine and urea in a reaction catalyzed by cytosolic (AI) or mitochondrial (AII) isoforms of arginase. Recent evidence suggests that the rate of NO generation is dependent on the relative activities of NO synthase and arginase. The objectives of this study were (i). to identify the arginase isoforms expressed in rat and human islets of Langerhans and a rat beta cell line, RINm5F and (ii). to investigate the competition for arginine between NO synthase and arginase in IL-1beta-treated rat islets. Arginase activity was detected in rat islets (fresh tissue, 346 mU/mg protein; cultured, 587 mU/mg), cultured human islets (56 mU/mg), RINm5F cells (376 mU/mg), rat kidney (238 mU/mg), and rat liver (6119 mU/mg). Using Western blots, AI was shown to be the predominant isoform expressed in rat islets and in RINm5F cells while human islets expressed far more AII than AI. Rat islets were cultured in medium containing 1.14, 0.1, and 0.01 mM arginine and treated with IL-1beta and the arginase inhibitor 2(S)-amino-6-boronohexanoic acid (ABH). IL-1beta-induced NO generation was unaffected by ABH at 1.14 mM arginine, but significantly increased at 0.1 and 0.01 mM arginine. These findings suggest that the level of islet arginase activity can regulate the rate of induced NO generation and this may be relevant to the insulitis process leading to beta cell destruction in type 1 diabetes.
促炎细胞因子诱导一氧化氮(NO)合成可能导致胰腺β细胞破坏,进而引发1型糖尿病。NO合酶的底物精氨酸也可在胞质(AI)或线粒体(AII)亚型精氨酸酶催化的反应中代谢为鸟氨酸和尿素。最近的证据表明,NO生成速率取决于NO合酶和精氨酸酶的相对活性。本研究的目的是:(i)鉴定在大鼠和人类胰岛以及大鼠β细胞系RINm5F中表达的精氨酸酶亚型;(ii)研究白细胞介素-1β(IL-1β)处理的大鼠胰岛中NO合酶和精氨酸酶对精氨酸的竞争情况。在大鼠胰岛(新鲜组织,346 mU/mg蛋白质;培养后,587 mU/mg)、培养的人类胰岛(56 mU/mg)、RINm5F细胞(376 mU/mg)、大鼠肾脏(238 mU/mg)和大鼠肝脏(6119 mU/mg)中检测到精氨酸酶活性。使用蛋白质免疫印迹法显示,AI是在大鼠胰岛和RINm5F细胞中表达的主要亚型,而人类胰岛中AII的表达量远高于AI。将大鼠胰岛培养在含有1.14、0.1和0.01 mM精氨酸的培养基中,并用IL-1β和精氨酸酶抑制剂2(S)-氨基-6-硼代己酸(ABH)处理。在1.14 mM精氨酸时,ABH对IL-1β诱导的NO生成无影响,但在0.1和0.01 mM精氨酸时显著增加。这些发现表明,胰岛精氨酸酶活性水平可调节诱导的NO生成速率,这可能与导致1型糖尿病中β细胞破坏的胰岛炎过程有关。